Skip to main content
. 2021 Jan 14;13(1):99. doi: 10.3390/pharmaceutics13010099

Figure 8.

Figure 8

In vitro anti-bacteria efficacy of nanoparticles against, (A) MRSA USA 300, (B) MRSA ATCC 43300 and (C) MSSA NTCT 8325. Bacteria were administrated with TR-701, PTR-701Ns and RPTR-701Ns at different TR-701 concentrations. Data were presented as mean ± SD (n = 6).